09.09.13
Aurora Spine Inc. has completed its initial public (IPO) offering of more than 5 million common shares. Priced at $0.70 per share, the offering made gross proceeds of $3.6 million. The shares will begin trading on the TSX Venture Exchange under the symbol “ASG” on Sept. 10.
Prior to the IPO, Aurora Spine became sole stockholder of the company, thereby gaining all of the proceeds. The majority of the proceeds will be used to fund costs associated with completing development, testing and launching of Aurora Spine’s second lumbar fusion device.
“We are very proud to have completed our IPO so successfully and to become a public company on the TSX Venture Exchange,” said Trent Northcutt, Aurora Spine’s president and CEO. “This is an important corporate milestone for Aurora Spine, and represents the culmination of the dedicated efforts of our experienced team. We believe this transaction will accelerate our position as a global spinal innovator of minimally invasive fusion, dynamic stabilization, and regenerative technologies.”
Aurora Spine makes minimally invasive, regenerative spinal implant technologies.
Prior to the IPO, Aurora Spine became sole stockholder of the company, thereby gaining all of the proceeds. The majority of the proceeds will be used to fund costs associated with completing development, testing and launching of Aurora Spine’s second lumbar fusion device.
“We are very proud to have completed our IPO so successfully and to become a public company on the TSX Venture Exchange,” said Trent Northcutt, Aurora Spine’s president and CEO. “This is an important corporate milestone for Aurora Spine, and represents the culmination of the dedicated efforts of our experienced team. We believe this transaction will accelerate our position as a global spinal innovator of minimally invasive fusion, dynamic stabilization, and regenerative technologies.”
Aurora Spine makes minimally invasive, regenerative spinal implant technologies.